Roche Polska Sp. z o. o. secures contract for Pharmaceutical products - Delivery of the medicinal product Crovalimab as part of the B96 Drug Program TREATMENT OF PATIENTS WITH NECTHAL PANICAL HEMOGLOBINURIA

Poland, Jan. 5 -- Poland based Roche Polska Sp. z o. o. has secured contract from UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU for Pharmaceutical products - Delivery of the medicinal product Crovalimab as part of the B96 Drug Program TREATMENT OF PATIENTS WITH NECTHAL PANICAL HEMOGLOBINURIA. The value of the contract is worth 306871740 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....